US Patent 7994289 Humanized anti-CD3 antibodies
Patent 7994289 was granted and assigned to BTG International Limited on August, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 18, 2003
0
Date of Patent
August 9, 2011
0
Patent Application Number
10463442
0
Patent Citations Received
Patent Inventor Names
Mark Frewin
0
Herman Waldmann
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7994289 Humanized anti-CD3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.